RM Law is investigating potential claims against the board of directors of Vascular Solutions, Inc. (“Vascular Solutions” or the “Company”) (NASDAQ: VASC) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell the Company to Teleflex Incorporated in a transaction valued at approximately $1.0 billion.
If you own shares of Vascular Solutions and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/vasc. You may also email Mr. Maniskas at firstname.lastname@example.org.
Under the terms of the agreement, shareholders of Vascular Solutions will receive $56.00 in cash for each share of Vascular Solutions common stock.
Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Vascular Solutions or not acting in the Company’s shareholders’ best interests in connection with the sale process.